Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $115.75 USD
Change Today -2.06 / -1.75%
Volume 2.0M
LH On Other Exchanges
New York
As of 8:04 PM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

F. Samuel Eberts III

Chief Legal Officer, Chief Compliance Officer, Senior Vice President and Secretary,Laboratory Corp. of America Holdings
AgeTotal Calculated CompensationThis person is connected to 14 board members in 2 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. F. Samuel Eberts, III, has been the President and Chief Executive Officer of Monogram Biosciences, Inc. since August 4, 2009 and serves as its Secretary. Mr. Eberts has been the Chief Compliance Officer, Chief Legal Officer and Secretary of Laboratory Corp. of America Holdings since January 1, 2009. Mr. Eberts has been Senior Vice President of Laboratory Corp. of America Holdings since August 2004. He serves as the President, Secretary and Director of Orchid Cellmark ...

Read Full Background

Corporate Headquarters*

358 South Main Street
Burlington, North Carolina 27215

United States

Phone: 336-229-1127
Fax: --

Board Members Memberships*

President, Secretary and Director
Chief Executive Officer, President, Secretary and Director


There is no Education data available.

Other Affiliations*

Annual Compensation*

Total Annual Compensation$436,085

Stock Options*

Restricted Stock Awards$572,834
All Other Compensation$17,083
Exercised Options10,000
Exercised Options Value$443,312
Exercisable Options50,700
Exercisable Options Value$1,595,771
Unexercisable Options3,800
Unexercisable Options Value$87,552
Total Value of Options$2,126,635
Total Number of Options64,500

Total Compensation*

Total Annual Cash Compensation$683,580
Total Short Term Compensation$436,085
Other Long Term Compensation$589,917
Total Calculated Compensation$1,331,146
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LH:US $115.75 USD -2.06


Josef H. von Rickenbach Founder, Chairman and Chief Executive Officer
PAREXEL International Corporation
Stephen P. Macmillan Chairman of the Board, Chief Executive Officer and President
Hologic Inc.
Neal L. Patterson Co-Founder, Chairman and Chief Executive Officer
Cerner Corporation
Stephen H. Rusckowski Chief Executive Officer, President, Director and Member of Executive Committee
Quest Diagnostics Inc.
Colin Stephen Goldschmidt M.B., B.Ch., F.R.C.P.A., F.A.I.C.D.Chief Executive Officer, Managing Director, Executive Director, Member of Risk Management Committee and Chief Executive Officer of Douglass Hanly Moir Pathology
Sonic Healthcare Limited
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LABORATORY CRP OF AMER HLDGS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at